[Congressional Record (Bound Edition), Volume 152 (2006), Part 12]
[House]
[Page 16169]
[From the U.S. Government Publishing Office, www.gpo.gov]




                       HONORING DR. ROCH DOLIVEUX

  Mr. GINGREY. Mr. Speaker, I ask unanimous consent to speak out of 
turn.
  The SPEAKER pro tempore. Without objection, the gentleman from 
Georgia is recognized for 5 minutes.
  There was no objection.
  Mr. GINGREY. Mr. Speaker, today I rise to commend a fine constituent 
of the 11th District of Georgia, Dr. Roch Doliveux. Dr. Doliveux is the 
chief executive officer of UCB, Incorporated, a leading global 
biopharmaceutical company with facilities in my district, the 11th of 
Georgia, in the town of Smyrna.
  Earlier this year, Dr. Doliveux received the Epilepsy Foundation's 
Distinguished Achievement Award in New York City. The Epilepsy 
Foundation annually recognizes individuals who have made outstanding 
efforts on the behalf of those living with epilepsy.
  As the CEO of UCB, Incorporated, Dr. Doliveux has spearheaded his 
company's efforts to raise awareness of this disease, and he has 
leveraged its resources to develop and provide medicines to help 
patients return to their daily activities.
  In our country, epilepsy affects 2.7 million Americans and their 
families. Mr. Speaker, epilepsy is a seizure disorder that can develop 
at any time in life, and it can stem from a variety of causes; but it 
is always a costly and frequently debilitating disease.
  That is why, as a physician Member, I am so proud to stand on the 
floor of this body and extend my congratulations to Dr. Doliveux for 
his fine work on behalf of the Epilepsy Foundation.

                          ____________________